|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/537 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 3597646 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19178148.3 |
| Date of filing the European patent application | 2017-08-17 | |
| (97) | Date of publication of the European application | 2020-01-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-21 |
| (46) | Date of publication of the claims translation | 2023-09-25 |
| (30) | Number | Date | Country code |
| 201662377312 P | 2016-08-19 | US | |
| 201762457555 P | 2017-02-10 | US |
| (72) |
GRAUPE, Michael , US
HENRY, Steven J. , US
LINK, John O. , US
ROWE, Charles William , US
SAITO, Roland D. , US
SCHROEDER, Scott D. , US
STEFANIDIS, Dimitrios , US
TSE, Winston C. , US
ZHANG, Jennifer R. , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapiniai junginiai, naudotini ŽIV viruso infekcijos profilaktikai ir terapiniam gydymui |
| THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 9 | 208.00 EUR |
| 2026-08-17 |